Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Breast 1

Conditions

Ovarian Neoplasms 1 Fasting 1 Breast Neoplasms 1

Interventions

pembrolizumab 33 Paclitaxel 27 Cyclophosphamide 25 Carboplatin 23 olaparib 21 Fulvestrant 15 fludarabine 14 Trastuzumab 14 aldesleukin 13 Docetaxel 13 Early Intervention, Educational 12 Surveys and Questionnaires 11 veliparib 10 palbociclib 10 Methods 10 Gemcitabine 10 Blood Specimen Collection 10 Nivolumab 9 Flow Cytometry 9 Biopsy 9 Bevacizumab 9 sargramostim 8 niraparib 7 liposomal doxorubicin 7 Therapeutics 7 Taxes 7 Standard of Care 7 Psychiatric Rehabilitation 7 Magnetic Resonance Spectroscopy 7 talazoparib 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasms × Diet, Vegan × Gynecologic × Clear all

NCT03162289 2022-12-13

FIT2

Charite University, Berlin, Germany

Phase NA Unknown

BreastGynecologic

Breast Neoplasms, Fasting, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡